Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

An Aging Interventions Testing Program: study design and interim report.

An Aging Interventions Testing Program: study design and interim report. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • An Aging Interventions Testing Program: study design and interim report. Abstract Text:

    richard a millerRichard A Miller,david e harrisonDavid E Harrison,clinton m astleClinton M Astle,robert a floydRobert A Floyd,kevin flurkeyKevin Flurkey,kenneth l hensleyKenneth L Hensley,martin a javorsMartin A Javors,christiaan leeuwenburghChristiaan Leeuwenburgh,james f nelsonJames F Nelson,ennio onginiEnnio Ongini,nancy l nadonNancy L Nadon,huber r warnerHuber R Warner,randy strongRandy Strong,

    The National Institute on Aging's Interventions Testing Program (ITP) has developed a plan to evaluate agents that are considered plausible candidates for delaying rates of aging. Key features include: (i) use of genetically heterogeneous mice (a standardized four-way cross), (ii) replication at three test sites (the Jackson Laboratory, TJL; University of Michigan, UM; and University of Texas, UT), (iii) sufficient statistical power to detect 10% changes in lifespan, (iv) tests for age-dependent changes in T cell subsets and physical activity, and (v) an annual solicitation for collaborators who wish to suggest new interventions for evaluation. Mice in the first cohort were exposed to one of four agents: aspirin, nitroflurbiprofen (NFP), 4-OH-alpha-phenyl-N-tert-butyl nitrone (4-OH-PBN), or nordihydroguiaretic acid (NDGA). An interim analysis was conducted using survival data available on the date at which at least 50% of the male control mice had died at each test site. Survival of control males was significantly higher, at the interim time-point, at UM than at UT or TJL; all three sites had similar survival of control females. Males in the NDGA group had significantly improved survival (P = 0.0004), with significant effects noted at TJL (P < 0.01) and UT (P < 0.04). None of the other agents altered survival, although there was a suggestion (P = 0.07) of a beneficial effect of aspirin in males. More data will be needed to determine if any of these compounds can extend maximal lifespan, but the current data show that NDGA reduces early life mortality risks in genetically heterogeneous mice at multiple test sites.

    An Aging Interventions Testing Program: study design and interim report. Publishing Authors By Initials

    ra millerRA Miller,de harrisonDE Harrison,cm astleCM Astle,ra floydRA Floyd,k flurkeyK Flurkey,kl hensleyKL Hensley,ma javorsMA Javors,c leeuwenburghC Leeuwenburgh,jf nelsonJF Nelson,e onginiE Ongini,nl nadonNL Nadon,hr warnerHR Warner,r strongR Strong,

    For similar investigative techniques: epidemiologic methods: statistics as topic: survival analysis research abstracts see: investigative techniques: epidemiologic methods: statistics as topic: survival analysis research

    PUBMED ID PMID:

    MEDLINE DATE:

    An Aging Interventions Testing Program: study design and interim report. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Aging cell

    VOLUME: 6

    Page Numbers: 565-75

    Journal Abbreviation: Aging Cell

    ISSN: 1474-9718

    DAY: 18

    MONTH: 06

    YEAR: 2007

    An Aging Interventions Testing Program: study design and interim report. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101130839

    An Aging Interventions Testing Program: study design and interim report. Keywords Mesh Terms:

    KEYWORDS: Survival Analysis

    MESH TERMS: pharmacology

    Chemical & Substance for Abstract: An Aging Interventions Testing Program: study design and interim report. Information

    Substance Name: Flurbiprofen

    Registry Number: 5104-49-4

    Grant and Affiliation Information for An Aging Interventions Testing Program: study design and interim report.

    AFFILIATION: Department of Pathology and Geriatrics Center, University of Michigan, Ann Arbor VA Medical Center, Ann Arbor, MI 48109-2200, USA. millerr@umich.edu

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NIA

    GRANT: AG13319

    ACRONYM: AG

    MEDLINETA: Aging Cell

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    An Aging Interventions Testing Program: study design and interim report Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News